Press

MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes

Sep 2 • 4 min read

Quick Take: MindMed and BioXcel have filed a patent that will help identify and prevent episodes of extreme agitated behavior in patients who may be more prone to agitation. MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (the “Company”), a leading biotech company developing psychedelic-inspired therapies, and BioXcel Therapeutics, Inc. (“BioXcel”), a leading clinical-stage biopharmaceutical company, announce…

Ketamine One to Deploy Cognetivity’s Integrated Cognitive Assessment Tool

Sep 1 • 4 min read

Quick Take: Ketamine One has reached a commercial agreement with Cognetivity Neurosciences and will begin to use their Integrated Cognitive Assessment in their clinics. The ICA enables long-term monitoring of cognitive performance in patients with treatment-resistant depression and PTSD. KetamineOne Capital Limited (NEO: MEDI, OTC: KONEF), a company focused on consolidating medical clinics and becoming…

Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit

Sep 1 • 4 min read

Quick Take: Red Light Holland has successfully exported 1.5 Kilograms of Psilocybe truffles grown at the company’s farm in Horst, Netherlands to its partner CCrest Laboratories in Montreal, Canada. Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of…

Small Pharma Announces Appointment of Lyne Fortin as Chair of the Board

Aug 30 • 3 min read

Quick Take: Ms. Fortin has served as a director for the company since April of this year, and will hold the Chair of the Board position until the next annual meeting of shareholders. Small Pharma Inc. (TSXV: DMT), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce that Ms. Lyne Fortin has been…

Braxia Scientific Comments on US Class Action

Aug 27 • 2 min read

Quick Take: The complaint alleges that the company and the individual defendants violated ss. 10(b) and 20(a) of the Securities Exchange Act. Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), today reported that it was served with a class action complaint against the Company, its former CEO and president, for the violation of US federal securities laws….

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441